Product Information
INDAPAMIDE 1.25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1087 per EA under NDC 16571087501. Its NADAC has been published 161 times since Sep 6, 2023.
FDA first approved this application on Mar 27, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571087501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
INDAPAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074461FDA Approved
3/27/1996
TE Code
AB
On Market Since
6/22/2023
Pharmacological Classes
Price Statistics
The NADAC for INDAPAMIDE 1.25 MG TABLET has been published 161 times since Sep 6, 2023, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1087 per EA |
|---|---|
| All-time high | $0.1243 (Apr 10, 2024) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1091 |
| 52-week low | $0.0993 |
| Median price | $0.1060 |
| Average price | $0.1069 |
| Largest weekly change | -29.9% (Nov 20, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Indapamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide-like Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INDAPAMIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INDAPAMIDE 1.25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1087 per EA (NDC 16571087501), effective Sep 30, 2026.
How has the price of INDAPAMIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for INDAPAMIDE 1.25 MG TABLET has declined 8.3%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for INDAPAMIDE 1.25 MG TABLET?
Since Sep 6, 2023, the NADAC for INDAPAMIDE 1.25 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.1243 (Apr 10, 2024), with a median of $0.1060 per EA.
Are there cheaper alternatives to INDAPAMIDE 1.25 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as INDAPAMIDE 1.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures INDAPAMIDE 1.25 MG TABLET?
INDAPAMIDE 1.25 MG TABLET (NDC 16571087501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.